{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:29Z","timestamp":1787070869429,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Brain metastasis (BM) from bone and soft tissue sarcomas (STS) is very rare and mostly predicts dismal prognosis. Owing to its\u2019 rarity, data on optimal therapy including surgical management, chemotherapy, and radiotherapy is scarce. We sought to assess the prevalence, disease characteristics, and outcomes of BM in bone and STS patients treated at a single institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective chart review was performed for consecutive bone and STS patients treated at King Hussein Cancer Center from 2007 to 2020. Patients with BM were identified. Survival was estimated by the Kaplan\u2013Meier method. Factors of possible effect on OS was examined in univariate analysis. Survival comparisons were carried out by the log-rank test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 1,548 bone and STS patients were treated at our center during the eligibility period. We identified 18 patients (1.1%) who had BM at initial presentation (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 16, 1.0%) or during follow up (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 2; 0.1%). Fourteen patients (77.8%) were male. The median age was 29.5 years (range: 0.1\u201360 years). The primary tumor was most commonly located in the extremities (61%). Ten different histopathological subtypes were encountered; Ewing sarcoma (ES) was the most common (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4; 28%). Twelve patients (67%) had lung metastasis as the first site of metastatic disease. BM was detected at a median time of 12 months following sarcoma diagnosis (range: 1\u201371 months). A total of 10 patients (56%) had solitary metastasis and 4 patients (22.2%) had hemorrhagic metastasis. The most common location of brain metastatic lesions was the occipital lobe (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4; 22.2%). Thirteen patients received treatment for metastatic brain sarcoma. The most common treatment modality was radiotherapy, received by a total of 10 patients (55.5%), followed by surgical intervention performed in a total of 5 patients (27.7%), The other treatment modalities included combined chemo-radiotherapy (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 2), targeted therapy plus chemotherapy, and targeted therapy plus radiotherapy (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1, each). At a median follow up of 10 months following detection of BM, the median OS was 4.0 months; (95% CI: 2.54\u20135.46). We did not identify any factor that influenced OS in univariate analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Sarcoma BM is exceedingly rare and herald\u2019s dismal prognosis. ES was a major histological subtype accounting for BM metastasis in our series.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_654_22","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:58:11Z","timestamp":1671152291000},"page":"S758-S763","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Sarcoma brain metastases: Tertiary cancer center experience"],"prefix":"10.4103","volume":"19","author":[{"given":"Hazim Sameer","family":"Ababneh","sequence":"first","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha\u2019eddin","family":"Muhsen","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Salah","family":"Fares","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawazen","family":"Hirbawi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Istishare Hospital, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala Al","family":"Awabdeh","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysa Al","family":"Hussaini","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rula","family":"Amarin","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdlatif Al","family":"Mousa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Salah","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Annals of Surgical Oncology"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3171\/2008.4.17505","article-title":"Surgical management of metastatic sarcoma to the brain","volume":"110","author":"Fox","year":"2009","journal-title":"J Neurosurg"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11060-009-0085-0","article-title":"Sarcoma metastatic to the brain: A series of 35 cases and considerations from 27 years of experience","volume":"98","author":"Salvati","year":"2010","journal-title":"J Neurooncol"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/1097-0142(197511)36:5<1843::AID-CNCR2820360541>3.0.CO;2-V","article-title":"Increased incidence of cerebral metastases in sarcoma patients with prolonged survival from chemotherapy. Report of cases of leiomysarcoma and chondrosarcoma","volume":"36","author":"Gercovich","year":"1975","journal-title":"Cancer"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"FSO756","DOI":"10.2144\/fsoa-2021-0077","article-title":"Metastatic myxoid liposarcoma of the brain: A case report and review of the literature","volume":"7","author":"Muhsen","year":"2021","journal-title":"Future Sci OA"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1245\/s10434-016-5559-7","article-title":"Sarcoma brain metastases: 28 years of experience at a single institution","volume":"23","author":"Al Sannaa","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1634\/theoncologist.2017-0136","article-title":"Brain metastases from adult sarcoma: Prognostic factors and impact of treatment. A retrospective analysis from the French Sarcoma Group (GSF\/GETO)","volume":"23","author":"Chaigneau","year":"2018","journal-title":"Oncologist"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"2036361320960060","DOI":"10.1177\/2036361320960060","article-title":"Brain metastases from Truncal and extremity bone and soft tissue sarcoma: Single institution study of oncologic outcomes","volume":"12","author":"Chan","year":"2020","journal-title":"Rare Tumors"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jjco\/29.5.245","article-title":"Brain metastases in musculoskeletal sarcomas","volume":"29","author":"Ogose","year":"1999","journal-title":"Jpn J Clin Oncol"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.bjc.6605373","article-title":"Brain metastases admissions in Sweden between 1987 and 2006","volume":"101","author":"Smedby","year":"2009","journal-title":"Br J Cancer"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0090-3019(97)00034-7","article-title":"Sarcoma metastatic to the brain: A series of 15 cases","volume":"49","author":"Salvati","year":"1998","journal-title":"Surg Neurol"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/ajco.12111","article-title":"Brain metastasis in sarcoma: Does metastasectomy or aggressive multi-disciplinary treatment improve survival outcomes","volume":"12","author":"Chua","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/cncr.10554","article-title":"Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients","volume":"94","author":"Espat","year":"2002","journal-title":"Cancer"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0090-3019(00)00293-7","article-title":"Brain metastasis in patients with sarcoma: An analysis of histological subtypes, clinical characteristics, and outcomes","volume":"54","author":"Yoshida","year":"2000","journal-title":"Surg Neurol"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/0046-8177(93)90121-V","article-title":"Alveolar soft part sarcoma: An unusually long interval between presentation and brain metastasis","volume":"24","author":"Lillehei","year":"1993","journal-title":"Hum Pathol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_654_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:56Z","timestamp":1787067476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_654_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":16,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_654_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]},"assertion":[{"value":"2022-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}